Titan Medical to Present at the 28th Annual Oppenheimer Healthcare Conference
Mar 15, 2018 11:30 am UTC| Business
TORONTO, March 15, 2018 -- Titan Medical Inc. (TSX:TMD) (OTCQB:TITXF) (“Titan” or the “Company”), a medical device company focused on the design and development of a robotic surgical system for application in minimally...
Albireo Reports Fourth Quarter and Year-End 2017 Financial Results
Mar 15, 2018 11:30 am UTC| Business
— Phase 3 PFIC trial of IBAT inhibitor A4250 planned to initiate in spring 2018 — — Elobixibat approved in Japan, becoming the first IBAT inhibitor approved in the world — — ~$200 million current cash balance expected...
Mar 15, 2018 11:30 am UTC| Business
NEW YORK, March 15, 2018 -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that preclinical data for TG-1601, the Company’s novel BET inhibitor, has been selected for presentation at the upcoming American...
Adaptimmune Reports Fourth Quarter / Full Year 2017 Financial Results and Business Update
Mar 15, 2018 11:30 am UTC| Business
- Responses observed in second solid tumor with NY-ESO providing further evidence of the potential of our SPEAR TCR T‑cell therapies to treat solid tumors - - Clinical momentum continues: dosing patients in MAGE-A4...
Adaptimmune Announces Responses in Second Solid Tumor Indication with NY-ESO SPEAR T-cells
Mar 15, 2018 11:30 am UTC| Business
PHILADELPHIA and OXFORD, U.K., March 15, 2018 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP), a leader in T-cell therapy to treat cancer, today reported three partial responses (two confirmed and one to be confirmed),...
Mar 15, 2018 11:30 am UTC| Business
HARRISBURG, Pa., March 15, 2018 -- Ollie’s Bargain Outlet Holdings, Inc. (Nasdaq:OLLI) announced today that it will release its financial results for the fourth quarter and full-year fiscal 2017 on Wednesday, April 4,...
Mar 15, 2018 11:18 am UTC| Business
Consolidated revenues € 1,288.1 million, +11.6%. EBITDA (1) € 454.7 million, +22.5% Operating income € 406.5 million, +24.1%. Net income € 288.8 million, +21.6%. Net financial position (2): net debt of € 381.8...